| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.911 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.745 | Human Mouse |
| sterol metabolic process | GO:0016125 | 58 | 0.733 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.689 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.681 | |
| positive regulation of lipoprotein lipase activity | GO:0051006 | 3 | 0.494 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.454 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.437 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.404 | |
| positive regulation of triglyceride lipase activity | GO:0061365 | 3 | 0.353 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.322 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.239 | |
| steroid metabolic process | GO:0008202 | 119 | 0.230 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.221 | |
| regulation of defense response | GO:0031347 | 233 | 0.209 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.206 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.198 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.198 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.195 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.179 | |
| urogenital system development | GO:0001655 | 261 | 0.176 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.168 | |
| regulation of lipase activity | GO:0060191 | 15 | 0.161 | |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.154 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.146 | Human |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.146 | |
| lipid catabolic process | GO:0016042 | 69 | 0.144 | |
| amine metabolic process | GO:0009308 | 45 | 0.144 | Human |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.142 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.142 | Human |
| transmembrane transport | GO:0055085 | 412 | 0.138 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.137 | |
| synaptic transmission | GO:0007268 | 329 | 0.134 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.130 | |
| cell adhesion | GO:0007155 | 329 | 0.128 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.127 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.122 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.122 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.121 | |
| protein maturation | GO:0051604 | 176 | 0.119 | |
| angiogenesis | GO:0001525 | 201 | 0.118 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.116 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.115 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.112 | |
| cellular response to peptide | GO:1901653 | 92 | 0.112 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.111 | |
| cytokine production | GO:0001816 | 319 | 0.110 | |
| fat cell differentiation | GO:0045444 | 160 | 0.109 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.108 | |
| response to peptide hormone | GO:0043434 | 127 | 0.108 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.108 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.107 | |
| protein glycosylation | GO:0006486 | 55 | 0.104 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.103 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.103 | |
| wound healing | GO:0042060 | 157 | 0.103 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.099 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.098 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.097 | |
| sterol transmembrane transport | GO:0035382 | 2 | 0.096 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.095 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.093 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.092 | Human |
| regulation of organelle organization | GO:0033043 | 289 | 0.089 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.088 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.088 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.088 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.086 | |
| cholesterol esterification | GO:0034435 | 3 | 0.082 | Human |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.082 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.082 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.079 | |
| glycosylation | GO:0070085 | 62 | 0.078 | |
| regulation of cell motility | GO:2000145 | 236 | 0.078 | |
| organic anion transport | GO:0015711 | 137 | 0.078 | |
| mapk cascade | GO:0000165 | 281 | 0.078 | |
| regulation of cell migration | GO:0030334 | 219 | 0.078 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.077 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.075 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.075 | Human |
| regulation of proteolysis | GO:0030162 | 164 | 0.073 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.072 | |
| immune effector process | GO:0002252 | 321 | 0.072 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.072 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.071 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.069 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.068 | |
| kidney development | GO:0001822 | 213 | 0.067 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.067 | |
| inflammatory response | GO:0006954 | 244 | 0.067 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.066 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.066 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.066 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.066 | |
| regulation of cell activation | GO:0050865 | 289 | 0.065 | |
| blood circulation | GO:0008015 | 195 | 0.065 | |
| dephosphorylation | GO:0016311 | 129 | 0.065 | |
| chemotaxis | GO:0006935 | 247 | 0.064 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.064 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.064 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.063 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.063 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.063 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.062 | Human |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.061 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.061 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.061 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.061 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.060 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.060 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.060 | Human |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.059 | |
| circulatory system process | GO:0003013 | 197 | 0.058 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.057 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.057 | |
| response to insulin | GO:0032868 | 100 | 0.057 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.057 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.057 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.056 | |
| cholesterol import | GO:0070508 | 2 | 0.056 | |
| t cell activation | GO:0042110 | 289 | 0.055 | |
| heart morphogenesis | GO:0003007 | 178 | 0.055 | |
| c4 dicarboxylate transport | GO:0015740 | 3 | 0.055 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.055 | |
| organelle fission | GO:0048285 | 170 | 0.054 | |
| protein processing | GO:0016485 | 163 | 0.054 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.054 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.053 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.052 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.052 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.052 | Human |
| renal system development | GO:0072001 | 225 | 0.052 | |
| forebrain development | GO:0030900 | 302 | 0.052 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.051 | |
| skeletal system development | GO:0001501 | 356 | 0.051 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.051 | |
| protein secretion | GO:0009306 | 111 | 0.051 | |
| regulation of phosphatidylcholine catabolic process | GO:0010899 | 2 | 0.050 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.050 | Rat |
| organ growth | GO:0035265 | 117 | 0.050 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.050 | |
| amino acid transport | GO:0006865 | 61 | 0.050 | |
| maintenance of location | GO:0051235 | 89 | 0.050 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.049 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.049 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.049 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.049 | |
| organophosphate ester transport | GO:0015748 | 28 | 0.049 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.049 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.049 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.049 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.048 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.048 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.048 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.048 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.048 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.047 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.047 | |
| nuclear division | GO:0000280 | 158 | 0.047 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.047 | |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.047 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.047 | |
| tissue remodeling | GO:0048771 | 102 | 0.046 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.046 | |
| positive regulation of lipid biosynthetic process | GO:0046889 | 18 | 0.046 | |
| regulation of secretion | GO:0051046 | 274 | 0.046 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.046 | |
| camera type eye development | GO:0043010 | 266 | 0.045 | |
| response to peptide | GO:1901652 | 136 | 0.045 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.045 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.045 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.045 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.044 | Human |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.044 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.044 | |
| vasodilation | GO:0042311 | 28 | 0.044 | |
| negative regulation of growth | GO:0045926 | 99 | 0.044 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.044 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.044 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.043 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.043 | |
| regulation of lipid catabolic process | GO:0050994 | 15 | 0.043 | |
| leukocyte migration | GO:0050900 | 124 | 0.043 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.041 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.041 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.041 | |
| activation of mapk activity | GO:0000187 | 59 | 0.041 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.041 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.041 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.040 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.040 | |
| hexose metabolic process | GO:0019318 | 98 | 0.040 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.040 | |
| innate immune response | GO:0045087 | 157 | 0.040 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.040 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.039 | |
| ossification | GO:0001503 | 216 | 0.039 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.039 | |
| neuron death | GO:0070997 | 154 | 0.039 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.039 | |
| positive regulation of growth | GO:0045927 | 104 | 0.039 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.038 | |
| carbohydrate transport | GO:0008643 | 62 | 0.038 | |
| phospholipid catabolic process | GO:0009395 | 5 | 0.038 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.038 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.038 | |
| epithelial cell development | GO:0002064 | 159 | 0.037 | |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.037 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.037 | |
| gland development | GO:0048732 | 330 | 0.037 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.037 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.037 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.037 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.037 | |
| organic acid transport | GO:0015849 | 101 | 0.037 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.037 | |
| cation homeostasis | GO:0055080 | 212 | 0.037 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.037 | |
| cell chemotaxis | GO:0060326 | 81 | 0.037 | |
| oxidation reduction process | GO:0055114 | 342 | 0.037 | |
| stem cell differentiation | GO:0048863 | 268 | 0.036 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.036 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.036 | |
| activation of immune response | GO:0002253 | 138 | 0.036 | |
| pallium development | GO:0021543 | 120 | 0.036 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.036 | Human |
| positive regulation of creb transcription factor activity | GO:0032793 | 4 | 0.036 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.035 | |
| adaptive immune response | GO:0002250 | 155 | 0.035 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.035 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.035 | |
| glucose homeostasis | GO:0042593 | 128 | 0.034 | |
| actin filament organization | GO:0007015 | 113 | 0.034 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.034 | |
| membrane organization | GO:0061024 | 245 | 0.034 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.034 | |
| sterol esterification | GO:0034434 | 3 | 0.034 | Human |
| forebrain cell migration | GO:0021885 | 58 | 0.033 | |
| regulation of protein processing | GO:0070613 | 96 | 0.033 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.033 | |
| germ cell development | GO:0007281 | 185 | 0.033 | |
| regulation of protein localization | GO:0032880 | 231 | 0.033 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.033 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.033 | |
| response to amino acid | GO:0043200 | 37 | 0.033 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.033 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.032 | |
| cerebral cortex development | GO:0021987 | 86 | 0.032 | |
| cation transport | GO:0006812 | 399 | 0.032 | |
| t cell differentiation | GO:0030217 | 174 | 0.032 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.031 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.031 | |
| telencephalon development | GO:0021537 | 186 | 0.031 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.031 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.031 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.031 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.031 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.031 | |
| chromatin organization | GO:0006325 | 206 | 0.030 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.030 | |
| lipid localization | GO:0010876 | 126 | 0.030 | Human |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.030 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.030 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.030 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.030 | |
| chromatin modification | GO:0016568 | 187 | 0.030 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.030 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.030 | |
| regulation of triglyceride biosynthetic process | GO:0010866 | 10 | 0.030 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.030 | |
| embryonic placenta development | GO:0001892 | 98 | 0.029 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.029 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.029 | Human |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.029 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.029 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.029 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.029 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.029 | |
| anion transport | GO:0006820 | 177 | 0.029 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.029 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.029 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.029 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.029 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.028 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.028 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.028 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.028 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.028 | |
| axonogenesis | GO:0007409 | 274 | 0.028 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.028 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.028 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.028 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.028 | |
| hexose transport | GO:0008645 | 56 | 0.028 | |
| connective tissue development | GO:0061448 | 179 | 0.028 | |
| sterol import | GO:0035376 | 2 | 0.028 | |
| regulation of coagulation | GO:0050818 | 31 | 0.028 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.028 | |
| sterol transport | GO:0015918 | 38 | 0.028 | Human |
| tissue homeostasis | GO:0001894 | 115 | 0.028 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.027 | |
| muscle tissue development | GO:0060537 | 308 | 0.027 | |
| digestive tract development | GO:0048565 | 190 | 0.027 | |
| renal system process | GO:0003014 | 48 | 0.027 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.027 | |
| extracellular structure organization | GO:0043062 | 148 | 0.027 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.027 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.027 | |
| response to inorganic substance | GO:0010035 | 96 | 0.027 | Rat |
| response to growth factor | GO:0070848 | 198 | 0.027 | |
| female gamete generation | GO:0007292 | 74 | 0.027 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.027 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.027 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.026 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.026 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.026 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.026 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.026 | |
| sterol homeostasis | GO:0055092 | 45 | 0.026 | Human |
| dicarboxylic acid transport | GO:0006835 | 29 | 0.026 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.026 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.026 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.026 | |
| regulation of bone remodeling | GO:0046850 | 28 | 0.026 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.026 | |
| dendritic spine organization | GO:0097061 | 26 | 0.026 | |
| heart contraction | GO:0060047 | 93 | 0.026 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.026 | |
| epidermis development | GO:0008544 | 187 | 0.026 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.026 | |
| activation of nf kappab inducing kinase activity | GO:0007250 | 4 | 0.026 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.026 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.026 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.026 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.026 | |
| mitochondrion organization | GO:0007005 | 134 | 0.025 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.025 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.025 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.025 | |
| regulation of system process | GO:0044057 | 200 | 0.025 | |
| cell growth | GO:0016049 | 130 | 0.025 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.025 | |
| male gamete generation | GO:0048232 | 285 | 0.025 | |
| response to oxidative stress | GO:0006979 | 123 | 0.025 | |
| monosaccharide transport | GO:0015749 | 58 | 0.025 | |
| response to monosaccharide | GO:0034284 | 67 | 0.025 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.025 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.025 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.025 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.024 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.024 | |
| multicellular organism growth | GO:0035264 | 161 | 0.024 | |
| regulation of ion transport | GO:0043269 | 215 | 0.024 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.024 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.024 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.024 | |
| layer formation in cerebral cortex | GO:0021819 | 13 | 0.024 | |
| steroid esterification | GO:0034433 | 3 | 0.024 | Human |
| placenta development | GO:0001890 | 140 | 0.024 | |
| spermatogenesis | GO:0007283 | 284 | 0.024 | |
| glial cell differentiation | GO:0010001 | 131 | 0.024 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.024 | |
| regulation of phospholipid catabolic process | GO:0060696 | 2 | 0.024 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.024 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.024 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.024 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.024 | |
| cell maturation | GO:0048469 | 127 | 0.024 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.024 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.024 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.024 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.024 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.024 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.024 | |
| septum primum development | GO:0003284 | 4 | 0.024 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.023 | |
| limbic system development | GO:0021761 | 72 | 0.023 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.023 | |
| dna metabolic process | GO:0006259 | 303 | 0.023 | |
| phospholipid transport | GO:0015914 | 21 | 0.023 | |
| response to corticosterone | GO:0051412 | 1 | 0.023 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.023 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.023 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.023 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.023 | |
| cellular amino acid catabolic process | GO:0009063 | 25 | 0.023 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.023 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.023 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.023 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.023 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.022 | |
| regulation of neuron death | GO:1901214 | 134 | 0.022 | |
| alcohol catabolic process | GO:0046164 | 16 | 0.022 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.022 | |
| negative regulation of dendritic spine development | GO:0061000 | 3 | 0.022 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.022 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.022 | |
| oogenesis | GO:0048477 | 56 | 0.022 | |
| ear development | GO:0043583 | 200 | 0.022 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.022 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.022 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.022 | |
| blood coagulation | GO:0007596 | 76 | 0.022 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.022 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.022 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.022 | |
| calcium ion transport | GO:0006816 | 159 | 0.022 | |
| regulation of activation of jak2 kinase activity | GO:0010534 | 1 | 0.022 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.022 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.022 | |
| regulation of presynaptic membrane organization | GO:1901629 | 3 | 0.022 | |
| nuclear transport | GO:0051169 | 139 | 0.022 | |
| low density lipoprotein particle clearance | GO:0034383 | 8 | 0.022 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.022 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.021 | |
| skin development | GO:0043588 | 220 | 0.021 | |
| hormone secretion | GO:0046879 | 128 | 0.021 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.021 | |
| exocytosis | GO:0006887 | 121 | 0.021 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.021 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.021 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.021 | |
| memory | GO:0007613 | 58 | 0.021 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.021 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.021 | |
| limb development | GO:0060173 | 166 | 0.021 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.021 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.021 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.021 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.020 | |
| digestive system development | GO:0055123 | 200 | 0.020 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.020 | Human |
| regulation of ossification | GO:0030278 | 112 | 0.020 | |
| response to acid chemical | GO:0001101 | 111 | 0.020 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.020 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.020 | |
| cellular homeostasis | GO:0019725 | 240 | 0.020 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.020 | |
| protein catabolic process | GO:0030163 | 221 | 0.020 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.020 | |
| regulation of tube size | GO:0035150 | 57 | 0.020 | |
| cholesterol transport | GO:0030301 | 38 | 0.020 | Human |
| bone resorption | GO:0045453 | 38 | 0.020 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.020 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.020 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.019 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.019 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.019 | |
| lipoprotein catabolic process | GO:0042159 | 7 | 0.019 | |
| protein ubiquitination | GO:0016567 | 171 | 0.019 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.019 | |
| endocytosis | GO:0006897 | 168 | 0.019 | |
| organelle assembly | GO:0070925 | 177 | 0.019 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.019 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.019 | |
| protein localization to organelle | GO:0033365 | 185 | 0.019 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.019 | |
| bone morphogenesis | GO:0060349 | 78 | 0.019 | |
| norepinephrine transport | GO:0015874 | 2 | 0.019 | |
| metanephric mesenchymal cell migration | GO:0035789 | 2 | 0.019 | |
| tissue migration | GO:0090130 | 68 | 0.019 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.019 | |
| glucose transport | GO:0015758 | 56 | 0.019 | |
| appendage development | GO:0048736 | 166 | 0.019 | |
| jak stat cascade | GO:0007259 | 42 | 0.019 | |
| lipid transport | GO:0006869 | 98 | 0.019 | Human |
| complement activation | GO:0006956 | 16 | 0.018 | |
| neuron projection guidance | GO:0097485 | 141 | 0.018 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.018 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.018 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.018 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.018 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.018 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.018 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.018 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.018 | |
| cellular response to lipid | GO:0071396 | 145 | 0.018 | |
| response to glucagon | GO:0033762 | 3 | 0.018 | |
| action potential | GO:0001508 | 78 | 0.018 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.018 | |
| regulation of adrenergic receptor signaling pathway | GO:0071877 | 4 | 0.018 | |
| cardiac septum development | GO:0003279 | 59 | 0.018 | |
| regulation of norepinephrine secretion | GO:0014061 | 2 | 0.018 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.018 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.018 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.018 | |
| cholesterol efflux | GO:0033344 | 24 | 0.018 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.018 | |
